BriLife LLC specializes in delivering a diverse array of services tailored to meet the needs of our healthcare partners in the medical and clinical practice fields. We offer a comprehensive range of services, including Immunology Diagnostics, Serology Testing, and Biochemical Analyses. BriLife LLC brings extensive experience and a proven track record in clinical research. Throughout the COVID-19 pandemic, BriLife played an active role in collaborative clinical research endeavors, including studies involving Zyesami Aviptadil and BriLife(IIBR-1000), alongside partners such as NRX Pharmaceuticals and Cromos Pharma.
| Website | https://brilife.co |
| Revenue | $1.4 billion |
| Employees | 463 (37 on RocketReach) |
| Founded | 2021 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Healthcare Services, Medical Services, Clinical Services, Immunology Diagnostics, Serology Testing, Medical Diagnostics, Healthcare Solutions, Clinical Diagnostics, Medical Testing, Lab Services, Diagnostic Testing, Healthcare Technology, Medical Technology, Clinical Laboratory, Healthcare Consulting, Medical Consulting, Patient Care, Health Services, Clinical Practice, Medical Practice |
| Competitors | Johnson & Johnson, Pfizer, Sanofi, GSK, AstraZeneca, Moderna Therapeutics, Novavax, CureVac, INOVIO Pharmaceuticals, Inc., Vaxart, Inc. +40 more (view full list) |
Looking for a particular BriLife employee's phone or email?
The BriLife annual revenue was $1.4 billion in 2026.
37 people are employed at BriLife.